Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved nodes, and number of nodes examined

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 5, 2000, Pages 1177-1183

  Iyer, Raj V ^a   Hanlon, Alexandra ^a   Fowble, Barbara ^a   Freedman, Gary ^a   Nicolaou, Nicos ^a   Anderson, Penny ^a   Hoffman, John ^a   Sigurdson, Elin ^a   Boraas, Marcia ^a   Torosian, Michael ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Axillary dissection; Axillary nodal positivity; Axillary nodes; Breast cancer

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BAYES THEOREM; BREAST CANCER; CANCER INVASION; CANCER STAGING; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEOPLASM STAGING; PROBABILITY;

EID: 0034662057     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00574-5     Document Type: Article

References (35)

1. Axelsson C.K., Mouridsen H.T., Zedeler K., et al. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer. 28A:1992;1415-1418.
2. Ciatto S., Pacini P., DelTurco M.R., et al. Patterns of axillary metastases in breast cancer. Radiother Oncol. 5:1986;91-94.
3. Fisher B., Wolmark N., Bauer M., et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet. 152:1981;765-772.
4. Kiricuta C.I., Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer. 69:1992;2496-2501.
5. Rose C.M., Botnick L.E., Weinstein M., et al. Axillary sampling in the definitive tratment of breast cancer by radiation therapy and lumpectomy. Int J Radiat Oncol Biol Phys. 9:1983;339-344.
6. Fisher B., Bauer M., Wickerham L., et al. Relation of number of positive axillary nodes to prognosis of patients with primary breast cancer. An NSABP update. Cancer. 52:1983;1551.
7. Recht A., Gray R., Davidson N.E., et al. Local-regional failure ten years following mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation Experience of the Easter Cooperative Oncology Group . J Clin Oncol. 17:1999;1689-1700.
8. Valagussa P., Bonadonna G., Veronesi U. Patterns of relapse and survival following radical mastectomy Analysis of 716 consecutive patients . Cancer. 41:1978;1170-1178.
9. Carter C.L., Allen C., Henson D.E. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer. 63:1989;181-187.
10. Nemoto T., Vana J., Bedwani R.N., et al. Management and survival of female breast cancer Results of a national survey by the American College of Surgeons . Cancer. 45:1980;2917-2924.
11. Fisher B., Slack N., Katrych D.L., et al. Ten year follow-up of patients in a cooperative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet. 140:1975;528-534.
12. Fowble B. Postmastectomy radiation Then and now . Oncology. 11:1997;213-239.
13. Vicini F.A., Horwitz E.M., Lacerna M.D., et al. The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 39:1997;1069-1076.
14. Danforth D.M., Findlay P.A., McDonald H.D., et al. Complete axillary lymph node dissection for stage I-II carcinoma of the breast. J Clin Oncol. 4:1986;655.
15. Veronesi U., Luini A., Galimberti S., et al. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol. 16:1990;127-133.
16. Veronesi U., Rilke F., Luini A. Distribution of axillary node metastases by level. Cancer. 59:1987;682.
17. Boova R.S., Bonani R., Rosato F.E. Patterns of axillary and nodal involvement in breast cancer predictability of level one dissection . Ann Surg. 196:1982;642.
18. Rosen P.P., Lesser M.L., Kinne D.W., et al. Discontinuous of "skip" metastases in breast carcinoma. Ann Surg. 187:1983;276.
19. Krag D., Weaver D., Ashikaga T., et al. The sentinel node in breast cancer. N Engl J Med. 339:1998;941-946.
20. Elston C.W., Gresham G.A., Rao G.S., et al. The Cancer Research Campaign (Kings's/Cambridge) trial for early breast cancer clinico-pathologic aspects . Br J Cancer. 45:1982;655-669.
21. Ragaz J., Jackson S.M., Nhu L., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 337:1997;956-962.
22. Willemse P.H.B., Otter R., Schaapveld M., et al. Quality analysis of axillary lymph node dissection in breast cancer patients in the northern part of the Netherlands. (Abstract) Proc Am Soc Clin Oncol. 18:1999;76a.
23. Fisher B., Slack N.H. Number of lymph nodes examined and the prognosis of breast carcinoma. Surg Gynecol Obstet. 131:1970;79-88.
24. Wilking N., Rutqvist L.E., Carstensen J., et al. Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Acta Oncol. 31:1992;29-35.
25. Korzeniowski S., Dyba T., Skolyszewski J. Classical prognostic factors for survival and loco-regional control in breast cancer patients treated with radical mastectomy alone. Acta Oncol. 33:1994;759-765.
26. Kahlert S.D., Konecny G., Nestle-Kraemling C., et al. Extent of axillary lymph node dissection - A source of misinterpretation but not a prognostic factor. (Abstract) Proc Am Soc Clin Oncol. 18:1999;76a.
27. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 337:1997;949-955.
28. Recht A. Local-regional failure rates in patients with involved axillary nodes after mastectomy and systemic therapy. Semin Radiat Oncol. 9:1999;223-229.
29. Overgaard M., Jensen M.-B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen Danish Breast Cancer Cooperative Group DBCG 82c randomized trial . Lancet. 353:1999;1641-1648.
30. Velez-Garcia E., Carpenter J.T. Jr, Moore M., et al. Post surgical adjuvant. chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes A Southeastern Cancer Study Group (SEG) Trial . Eur J Cancer Clin Oncol. 28A:1992;1833-1837.
31. Fowble B. Postmastectomy radiation in patients with one to three positive axillary nodes receiving adjuvant chemotherapy An unresolved issue . Semin Radiat Oncol. 9:1999;230-240.
32. Recht A., Galper S.R., Silver B., et al. Factors associated with regional node failure in patients with early stage breast cancer with 0 to 3 positive axillary nodes following tangential breast irradiation alone. (Abstract) Int J Radiat Oncol Biol Phys. 42:1998;181.
33. Reynolds C., Mick R., Donohue J.H., et al. Sentinel lymph node biopsy with metastases Can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol. 17:1999;1720-1726.
34. Chu K.U., Turner R.R., Hansen N.M., et al. Do all patients with sentinel node metastases from breast carcinoma need complete axillary dissection? Ann Surg. 229:1999;536-541.
35. Veronesi U., Paganelli G., Viale G., et al. Sentinel lymph node biopsy and axillary dissection in breast cancer Results in a large series . J Natl Cancer Inst. 91:1999;368-373.